Catalyst Wire Dossier Catalyst Wire Dossier

EH002 gene therapy

EH002
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EH002 gene therapy, covering 2025-07-25 to 2025-07-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss [NA]

See pricing